Mid-Tier Player Profiles: LimaCorporate, Medartis and AK Medical
A look into three companies outside the U.S. in the $100 million to $300 million revenue bracket: LimaCorporate, Medartis and AK Medical.
3 Takeaways on the Orthopedic Market in Europe Today
Matt Woods, Founder of Ortho Consulting Group, touched on three key points as the European orthopedic market adapts in these unpredictable times: the cancellation of industry meetings due to COVID could slow the pace of innovation, EU Medical Device Regulation (MDR), and accelerating M&A activity.
Colson Medical Announces Merger of Acumed and OsteoMed
Acumed and OsteoMed, both owned by Colson Medical, will gradually integrate over the coming year under the leadership of Acumed CEO Sharon Wolfington.
Globus Medical Acquires Stake in Synoste from Evonik
Globus Medical acquired all of Evonik's shares in Synoste, a Finnish startup. Synoste's limb-lengthening technology could bolster Globus' trauma business.
DJO Global Emerges as Buyer for Stryker Divestitures
To clear regulatory issues related to its purchase of Wright Medical, Stryker proposed DJO as a buyer for certain ankle and finger joint replacement lines.
DePuy Synthes Improvement Driven by Quicker U.S. Recovery
Orthopedic procedure volumes improved more quickly than expected in the U.S., helping DePuy Synthes close 3Q20 down -2.6% compared to the prior year.
Avoiding the Doom Loop: Innovation Realities for Orthopedic Startups
Startups must focus very tightly on a specific target market and value proposition to have the best chance of avoiding the doom loop of medtech innovation.
3Q Earnings Preview: Orthopedic Market Could Struggle to Maintain Momentum
While the orthopedic market recovered faster than expected in the second quarter, we saw indications of deceleration heading into the third quarter.
Surgalign Announces Agreement to Acquire HoloSurgical
Surgalign Holdings will enter the digital surgery space by acquiring HoloSurgical and it's Augmented Reality and Artificial Intelligence (ARAI) platform.
Integra LifeSciences to Sell Extremity Orthopedics Business to Smith+Nephew
Integra Lifesciences announced a definitive agreement to divest its Extremity Orthopedics business to Smith+Nephew for $240 million.